CLINICAL_TRIALS withdrawal · 2017-05-05

Clinical Trial Update: Evaluation of a Nasal Allergen Challenge Procedure Using Dust Mite Extract [Phase 1]

Phase 1 evaluation of a nasal allergen challenge using dust mite extract was withdrawn. The study targeted dust mite allergy and asthma.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: University of North Carolina, Chapel Hill | Conditions: Dermatophagoides Farinae Allergy, Asthma | Phase 1 | Status: WITHDRAWN